Review Article

Muscle Plasticity and -Adrenergic Receptors: Adaptive Responses of -Adrenergic Receptor Expression to Muscle Hypertrophy and Atrophy

Table 1

Responses of β 2-AR expression in skeletal muscle to anabolic and catabolic conditions.

ConditionsSpeciesβ 2-AROther findingsReferences
ProteinmRNA

β 2-AR stimulation
 FenoterolRat (FT)n.d.[4]
 (1.4  , 4 weeks) (ST)
 ClenbuterolRatn.d. (FT) 1-AR mRNA (LV)[7]
 (1.0  , 10 days) (ST)β 2-AR mRNA (LV)
 ClenbuterolRatn.d. (FT)GR mRNA (FT)[8]
 (1.0  , 10 days) (ST)HuR mRNA (FT)
AUF1 mRNA (FT)
hnRNP A1 mRNA (FT)
 FenoterolRat (FT, ST) (FT, ST)G content (FT, ST)[14]
 (1.4  , 2–7 days)AC activity (FT, ST)
 ClenbuterolRat (FT+ST)n.d.[15]
 (2.0  , 18 days)
 ClenbuterolRat (FT)n.d.β 2-AR affinity (FT)[16]
 (4.0  of feed, 10 days)
 ClenbuterolRat (FT+ST)n.d.[17]
 (0.2  , 7 days)
 Clenbuterol (50 μM)Mouse (ex vivo)Phosphorylatedn.d.cAMP concentration [41]
 Formoterol (100 μM) -AR (ST),(FT, ST)
 Salbutamol (500 μM) (FT)

Endurance training
 Treadmill (12 weeks)Rat (FT)n.d.β 2-AR afflnity [18]
AC activty
G content
 Treadmill (18 weeks)Rat (FT)n.d.AC activity (FT, ST)[19]
(ST)β 2-AR density (acute)

Catabolic conditions
 DexamethasoneRat (FT, ST) (FT)GR mRNA (FT, ST)[20]
 (1.0  , 10 days) (ST)CREB mRNA (ST)
AUF1 mRNA (FT)
 DexamethasoneRatn.d. (FT)GR mRNA (FT, ST)[21]
 (1.0  , 10 days) (ST)β 1-AR mRNA (LV)
 DexamethasoneRat (FT)n.d.β 2-AR affinity (FT)[16]
 (0.2  , 10 days)
 Casted-immobilizationRat (FT, ST) (FT)GR mRNA (ST)[22]
 (10 days) (ST)GR protein (ST)
 AgingRat (FT, ST)n.d.[4]
 InjuryRat (FT) (FT)G content (FT), (ST)[14]
 (bupivacaine injection) (ST) (ST)AC activity (FT, ST)

FT, fast-twitch muscle; ST, slow-twitch muscle; LV, left ventricle muscle. Up arrow, increase; down arrow, decrease; lateral arrow, no change. n.d., no data.